Patents by Inventor Miguel Rodríguez

Miguel Rodríguez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6281315
    Abstract: The present patent of invention describes the obtention of lasers in solid condition of dyes of the family of Rhodamines. More particularly, it describes lasers in which said dye or chromophore is to be found covalently anchored to a solid matrix, consisting in a transparent organic polymer and suficiently stable to the pumping radiation. Its application is the production of the laser emittance by an organic dye in a solid matrix and polymers containing rhodamines.
    Type: Grant
    Filed: June 12, 1997
    Date of Patent: August 28, 2001
    Assignee: Consejo Superior Investigaciones Cientificas
    Inventors: Angel Costela Gonzalez, Immaculada Garcia Moreno, Juan Manuel Figuera Acebal, Miguel Rodriguez Artigas, Alberto Ulíses Acu{overscore (n)}a Fernandez, Francisco Amat Guerri, Roberto Sastre Mu{overscore (n)}oz
  • Patent number: 6084075
    Abstract: The invention relates to antibodies which is capable of binding the monocyte chemoattractant protein 1 (MCP-1) receptor CCR2, especially those which are capable of acting either as an antagonist or agonist. The claimed antobodies can be used for in vitro and/or in vivo diagnostic, for screening and detection of tissues and classes of cells expressing the MCP-1 receptor, for screening for new drugs and for therapeutic use. The invention also relates to a preparation comprising the claimed antibody and a micro-organism or cell-line capable of producing the claimed antibody.
    Type: Grant
    Filed: February 28, 1997
    Date of Patent: July 4, 2000
    Assignees: Pharmacia & Upjohn AB, Consejo Superior de Investigaciones
    Inventors: Peter Lind, Carlos Martinez Alonso, Jose Mario Mellado Garcia, Jose Miguel Rodriguez Frade
  • Patent number: 5945296
    Abstract: The invention relates to monoclonal antibody capable of specific binding to the molecular weight of 20 kDa variant of human growth hormone. This monoclonal antibody has no substantial binding to hGH of molecular weight 22 kDa. The invention also relates to the use of this monoclonal antibody for measurement of hGH 20K, especially in body fluids. The antibodies can be used for detection and quantification of hGH 20K, especially in serum.
    Type: Grant
    Filed: March 28, 1997
    Date of Patent: August 31, 1999
    Assignees: Pharmacia & Upjohn AB, Consejo Superior de Investigaciones
    Inventors: Yngve Elof Hansson, Leonor Kremer Baron, Carlos Martinez Alonso, Jose Mario Mellado Garcia, Jose Miguel Rodriguez Frade
  • Patent number: 5564072
    Abstract: A fixed cellular communications system consisting of a cellular mobile communications network (CS) that provides coverage of voice and/or data communications services to terminals located in a set of cells in any one of which there can be at least one fixed cellular terminal (4) that communicates, on one side, by radio, with one of the base stations (3) of the cellular mobile communications network (CS) and on the other side, by cable, with at least one base station (6) of a cordless communications system (WS) through control and interface means that perform the adaptation between the two systems to provide communications services to a number of cordless terminals (7).
    Type: Grant
    Filed: September 29, 1994
    Date of Patent: October 8, 1996
    Assignee: Alcatel N.V.
    Inventors: Jose Maria Garcia Aguilera, Miguel Rodriguez-Palanca Pliego, Francisco C. Beneyto, Juan A. Garcia Perez